Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1446194 BALA CYNWYD, PA

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,564,142
+$24,993,564 QoQ
Shares Held
754,327
+4131.8% QoQ
Ownership
0.631%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#29
of 197 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Derivatives in NAMS

reported options exposure · as of Jun 30, 2026
CallValue
$5,015,720
CallShares
148,000
PutValue
$19,269,854
PutShares
568,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. NAMS ranks #17 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NAMS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,564,142 754,327
2026-06-30 $5,015,720 148,000
2026-06-30 $19,269,854 568,600
2026-03-31 $570,578 17,825
2026-03-31 $5,973,066 186,600
2026-03-31 $8,354,610 261,000
2025-12-31 $7,061,604 201,300
2025-12-31 $6,862,875 195,635
2025-12-31 $4,149,964 118,300
2025-09-30 $4,318,244 151,837
2025-09-30 $3,919,032 137,800
2025-06-30 $237,241 13,100
2025-06-30 $1,347,384 74,400
2025-06-30 $1,626,766 89,827
2025-03-31 $3,050,766 149,036
2025-03-31 $1,770,655 86,500
2024-12-31 $992,020 38,600
2024-12-31 $1,395,510 54,300
2024-12-31 $230,426 8,966
2023-12-31 NAMSW $57,338 18,319